You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 22, 2011

Clemence Gautier to Speak on Clinical Trials

On May 20, 2011, Clemence Gautier, Consultant, Intellectual Property, will speak at what has been billed as the most comprehensive forum on clinical trials in Thailand. Clinical Trial Forum Thailand 2011 aims to assemble key opinion leaders from the government, research institutes, service providers, originators, and other stakeholders to discuss contemporary challenges in the Thailand market.

Clemence Gautier will present on “Overcoming Regulatory and Patent Roadblocks for Clinical Trials in Asia: Thailand and Vietnam,” which will provide practical tips for ensuring smooth clinical trials in Thailand, from both a regulatory and a contractual perspective. For more information on Clinical Trial Forum Thailand 2011, access the Lawson-Marsh website.

RELATED INSIGHTS​ 

April 26, 2012
Three members of the Tilleke & Gibbins team have been named to The International Who’s Who of Life Sciences Lawyers 2012. Published by Law Business Research, the official research partner of the International Bar Association, this guide identifies 546 experts in 48 jurisdictions who are considered leaders in serving clients in the life sciences sector.The Tilleke & Gibbins attorneys recognized by the publication are:
December 28, 2011
Oxford Business Group (OBG), the global publishing, research and consultancy company, has renewed its partnership with Tilleke & Gibbins for its latest report on Thailand’s economy.As part of the collaboration, which marks OBG’s third year of partnership with the law firm, Tilleke & Gibbins will work with the Group’s editorial and research team to produce the legal section of The Report: Thailand 2012.
October 17, 2011
As of January 1, 2011, ASEAN harmonization registration of cosmetics has been fully implemented in Thailand. The Thai FDA now requires that the distributor or marketing authorization holder maintain a Product Information File (PIF) at their office.